Silence Therapeutics PLC Holding(s) in Company (0090P)
February 12 2021 - 10:53AM
UK Regulatory
TIDMSLN
RNS Number : 0090P
Silence Therapeutics PLC
12 February 2021
TR-1: S tandard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and
to the FCA in Microsoft Word format if possible) (i)
1a. Identity of the issuer or the Silence Therapeutics Plc
underlying issuer of existing shares
to which voting rights are attached
(ii) :
--------------------------------------------
1b. Please indicate if the issuer is a non-UK issuer (please mark with
an "X" if appropriate)
Non-UK issuer
----
2. Reason for the notification (please mark the appropriate box or boxes
with an "X")
An acquisition or disposal of voting rights
----
An acquisition or disposal of financial instruments
----
An event changing the breakdown of voting rights
----
Other (please specify)(iii) : Dilution on placing of shares X
----
3. Details of person subject to the notification obligation (iv)
Name Richard Griffiths and controlled
undertakings
City and country of registered office St Helier, Jersey
(if applicable)
4. Full name of shareholder(s) (if different from 3.) (v)
Name
--------------------------------------------
City and country of registered office
(if applicable)
--------------------------------------------
5. Date on which the threshold was 10 February 2021
crossed or reached (vi) :
--------------------------------------------
6. Date on which issuer notified (DD/MM/YYYY): 12 February 2021
--------------------------------------------
7. Total positions of person(s) subject to the notification obligation
% of voting % of voting rights Total of both Total number
rights attached through financial in % (8.A + of voting rights
to shares (total instruments 8.B) of issuer (vii)
of 8. A) (total of 8.B
1 + 8.B 2)
------------------ --------------------- -------------- --------------------
Resulting situation
on the date
on which threshold
was crossed
or reached 21.99% 3.97% 25.96% 89,381,913
------------------ --------------------- -------------- --------------------
Position of
previous notification
(if
applicable) 27.47% 0.75% 28.21%
------------------ --------------------- -------------- --------------------
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached (viii)
A: Voting rights attached to shares
Class/type of Number of voting rights % of voting rights
shares (ix)
ISIN code (if
possible)
Direct Indirect Direct Indirect
(Art 9 of Directive (Art 10 of Directive (Art 9 of Directive (Art 10 of Directive
2004/109/EC) 2004/109/EC) 2004/109/EC) (DTR5.1) 2004/109/EC)
(DTR5.1) (DTR5.2.1) (DTR5.2.1)
-----------------------
GB00B9GTXM62 19,655,648 0 21.99% 0.00%
---------------------- ----------------------- ----------------------------- --------------------------
SUBTOTAL 8. A 19,655,648 21.99%
----------------------------------------------- ---------------------------------------------------------
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC
(DTR5.3.1.1 (a))
Type of financial Expiration Exercise/ Number of voting % of voting
instrument date Conversion Period rights that may rights
(x) (xi) be acquired if
the instrument
is
exercised/converted.
------------ ----------------------- --------------------------------------- --------------------------
ADR US82686Q1013 1,210,000 1.35%
------------ ----------------------- --------------------------------------- --------------------------
SUBTOTAL 8. B 1 1,210,000 1.35%
----------------------- --------------------------------------- --------------------------
B 2: Financial Instruments with similar economic effect according to
Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of Expiration Exercise/ Physical Number of % of voting
financial date (x) Conversion Period or cash voting rights rights
instrument (xi) settlement
(xii)
------------------ ----------------------- --------------------- ----------------
CFD Cash 2,337,351 2.62%
--------------- ----------------------- --------------------- ----------------
SUBTOTAL
8.B.2 2,337,351 2.62%
--------------------- ----------------
9. Information in relation to the person subject to the notification
obligation (please mark the
applicable box with an "X")
Person subject to the notification obligation is not controlled
by any natural person or legal entity and does not control any
other undertaking(s) holding directly or indirectly an interest
in the (underlying) issuer (xiii)
Full chain of controlled undertakings through which the voting X
rights and/or the
financial instruments are effectively held starting with the
ultimate controlling natural person or legal entity (xiv) (please
add additional rows as necessary)
Name (xv) % of voting rights % of voting rights Total of both
if it equals through financial if it equals
or is higher instruments if or is higher
than the notifiable it equals or is than the notifiable
threshold higher than the threshold
notifiable threshold
----------------------- ----------------------------------- ---------------------------
Sarossa Plc 2.45% 2.45%
----------------------- ----------------------------------- ---------------------------
Oak Trust Limited 0.31% 0.31%
----------------------- ----------------------------------- ---------------------------
Richard Griffiths 12.70% 3.97% 16.67%
----------------------- ----------------------------------- ---------------------------
Ora Ventures Limited 5.59% 5.59%
----------------------- ----------------------------------- ---------------------------
Cream Capital Limited 0.94% 0.94%
----------------------- ----------------------------------- ---------------------------
Total 21.99% 3.97% 25.96%
----------------------- ----------------------------------- ---------------------------
10. In case of proxy voting, please identify:
Name of the proxy holder N/A
----------------------------------------------------------------
The number and % of voting rights held N/A
----------------------------------------------------------------
The date until which the voting rights N/A
will be held
----------------------------------------------------------------
11. Additional information (xvi)
Place of completion St Helier, Jersey, Channel Islands
Date of completion 12 February 2021
-----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
HOLUUSNRAKUUAAR
(END) Dow Jones Newswires
February 12, 2021 11:53 ET (16:53 GMT)
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Silence Therapeutics (LSE:SLN)
Historical Stock Chart
From Apr 2023 to Apr 2024
Real-Time news about Silence Therapeutics Plc (London Stock Exchange): 0 recent articles
More Silence Therapeutics Plc News Articles